Flow Traders U.S.’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Flow Traders U.S.’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,070	Closed	–	–	1247
2023 Q1	$0	Sell	10,070 -3,895	-28%	-$375	﹤0.01%	1212
2022 Q4	$2K	Buy	13,965 +186	+1%	+$30	﹤0.01%	728
2022 Q3	$2K	Buy	13,779 +492	+4%	+$72	﹤0.01%	893
2022 Q2	$2K	Buy	+13,287	New	+$6.57K	﹤0.01%	785

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Flow Traders U.S.'s PEARW Position: Q2 2023 in Review

Flow Traders U.S. sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 10,070 shares.

Flow Traders U.S. first reported a position in PEARW in Q2 2022 and held it in 4 quarters. The position peaked at $2K in Q4 2022. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Flow Traders U.S. reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Flow Traders U.S. sold 10,070 Pear Therapeutics, Inc. Warrant shares in Q2 2023.
Flow Traders U.S. first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2022 and held it in 4 quarters.
Flow Traders U.S.'s Pear Therapeutics, Inc. Warrant position peaked at $2K in Q4 2022.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Flow Traders U.S.'s 13F filing for Q2 2023, filed 9 Aug 2023.